Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 80 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 7976868

    Liposomes comprising duramycin and anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  2. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  3. US 7960133

    Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

    The Board of Regents of the University of Texas System · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  4. US 7951356

    Tissue factor compositions and kits for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted

  5. US 7951362

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted

  6. US 7943332

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted May 17, 2011 · Expires May 12, 2031

    granted

  7. US 7928062

    Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

    The Board of Regents of the University of Texas System · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  8. US 7927833

    Composition and method for enhancing immune response

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  9. US 7923010

    Methods and materials for treating autoimmune diseases and conditions

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  10. US 7923548

    Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  11. US 7923014

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  12. US 7919613

    RNAi modulation of SCAP and therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  13. US 7919579

    Imaging and therapeutic targeting of prostate and bladder tissues

    The Board of Regents of the University of Texas System · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  14. US 7914780

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  15. US 7915245

    Methods and compositions of trail-death receptor agonists/activators

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  16. US 7906555

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  17. US 7906628

    Targeting proteins to deliver therapeutic or diagnostic reagents

    The Board of Regents of the University of Texas System · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  18. US 7902166

    Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  19. US 7897340

    Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker

    The Board of Regents of the University of Texas System · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  20. US 7892567

    Methods and compositions for immunization against chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  21. US 7893033

    Targeting proteins to deliver therapeutic or diagnostic reagents

    The Board of Regents of the University of Texas System · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  22. US 7893027

    Treatment of ocular wounds and ulcers

    The Board of Regents of the University of Oklahoma · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  23. US 7887836

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  24. US 7884211

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.